From Fukuoka University, School of Medicine, Department of Internal
Medicine, Fukuoka City, Japan.
Correspondence to Hidenori Urata, MD, Fukuoka University, School of Medicine, Department of Internal Medicine, 7–45-1 Nanakuma, Jonan-ku, Fukuoka 814–0180, Japan. E-mail uratah{at}msat.fukuoka-u.ac.jp
Abstract—Angiotensin
(Ang) II plays an important role in cardiovascular
homeostasis, not only in the systemic circulation but also at the
tissue level, and is involved in the remodeling of the heart and
vasculature under pathological conditions. Although alternative Ang
II–forming pathways are known to exist in various tissues, the details
of such pathways remain unclear. The aim of this study was to examine
tissue Ang II–forming activities and to identify the responsible
enzyme in several organs (lung, heart, and aorta) in various species
(human, hamster, rat, rabbit, dog, pig, and marmoset). Among the organs
examined, the lung contained the highest Ang II–forming activity. The
responsible enzyme for pulmonary Ang II formation was
angiotensin I-converting enzyme (ACE) in all of the species
except the human lung, in which a chymaselike enzyme was dominant. In
the heart, the highest total Ang II–forming activity was observed in
humans, and a chymaselike enzyme was dominant in all of the species
except rabbit and pig. Aorta exhibited a relatively high total Ang
II–forming activity, with a predominance of chymaselike activity in
all of the species except rabbit and pig, in which ACE was dominant.
Our results indicate that there were remarkable differences in Ang
II–forming pathways among the species and organs we examined. To study
the pathophysiological roles of ACE-independent Ang
II formation, one should choose species and/or organs that have Ang
II–forming pathways similar to those in humans.
© 1998 American Heart Association, Inc.
Scientific Contributions
Differences in Tissue Angiotensin II–Forming Pathways by Species and Organs In Vitro
Key Words: angiotensin-converting enzyme • chymase • kallikrein • heart • lung • aorta
This article has been cited by other articles:
 |
|
 |
|
  Y. Ochiai, Y.-Q. Liang, M. Serizawa, and N. Kato Dynamic changes of the renin-angiotensin and associated systems in the rat after pharmacological and dietary interventions in vivo Physiol Genomics, November 12, 2008; 35(3): 330 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Lavrentyev, A. M. Estes, and K. U. Malik Mechanism of High Glucose Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells Circ. Res., August 31, 2007; 101(5): 455 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Vinik and D. Ziegler Diabetic Cardiovascular Autonomic Neuropathy Circulation, January 23, 2007; 115(3): 387 - 397. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, J. Zhang, G. Spinetti, L.-Q. Jiang, R. Monticone, D. Zhao, L. Cheng, M. Krawczyk, M. Talan, G. Pintus, et al. Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats Am. J. Pathol., November 1, 2005; 167(5): 1429 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohta, N. Hasebe, S. Tsuji, K. Izawa, Y.-T. Jin, S. Kido, S. Natori, M. Sato, and K. Kikuchi Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2914 - H2921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A Doggrell and J. C Wanstall Vascular chymase: pathophysiological role and therapeutic potential of inhibition Cardiovasc Res, March 1, 2004; 61(4): 653 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Marchetti, C. M. B. Helou, C. Chollet, R. Rajerison, and F. Alhenc-Gelas Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: ACE and non-ACE mediated effect of angiotensin I on intracellular calcium mobilization in rat glomerular arterioles Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1933 - H1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, G. Takagi, K. Asai, R. G. Resuello, F. F. Natividad, D. E. Vatner, S. F. Vatner, and E. G. Lakatta Aging Increases Aortic MMP-2 Activity and Angiotensin II in Nonhuman Primates Hypertension, June 1, 2003; 41(6): 1308 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Kokkonen, K. A. Lindstedt, and P. T. Kovanen Role For Chymase in Heart Failure: Angiotensin II-Dependent or -Independent Mechanisms? Circulation, May 27, 2003; 107(20): 2522 - 2524. [Full Text] [PDF]
|
|
|
|
|
|
T. Matsumoto, A. Wada, T. Tsutamoto, M. Ohnishi, T. Isono, and M. Kinoshita Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure Circulation, May 27, 2003; 107(20): 2555 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Tom, I. M. Garrelds, E. Scalbert, A. P.A. Stegmann, F. Boomsma, P. R. Saxena, and A.H. J. Danser ACE- Versus Chymase-Dependent Angiotensin II Generation in Human Coronary Arteries: A Matter of Efficiency? Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 251 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. McDonald, N. Padmanabhan, M. C. Petrie, C. Hillier, J. M.C. Connell, and J. J.V. McMurray Vasoconstrictor Effect of the Angiotensin-Converting Enzyme-Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans Circulation, October 9, 2001; 104(15): 1805 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Rouleau, G. Kapuku, S. Pelletier, H. Gosselin, A. Adam, C. Gagnon, C. Lambert, and S. Meloche Cardioprotective Effects of Ramipril and Losartan in Right Ventricular Pressure Overload in the Rabbit: Importance of Kinins and Influence on Angiotensin II Type 1 Receptor Signaling Pathway Circulation, August 21, 2001; 104(8): 939 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kushiku, H. Yamada, K. Shibata, R. Tokunaga, T. Katsuragi, and T. Furukawa Upregulation of Immunoreactive Angiotensin II Release and Angiotensinogen mRNA Expression by High-Frequency Preganglionic Stimulation at the Canine Cardiac Sympathetic Ganglia Circ. Res., January 19, 2001; 88(1): 110 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Arakawa and H. Urata Hypothesis Regarding the Pathophysiological Role of Alternative Pathways of Angiotensin II Formation in Atherosclerosis Hypertension, October 1, 2000; 36(4): 638 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. van Kats, D. J. Duncker, D. B. Haitsma, M. P. Schuijt, R. Niebuur, R. Stubenitsky, F. Boomsma, M. A. D. H. Schalekamp, P. D. Verdouw, and A. H. J. Danser Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade Prevent Cardiac Remodeling in Pigs After Myocardial Infarction : Role of Tissue Angiotensin II Circulation, September 26, 2000; 102(13): 1556 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S Weinberg, A. J Weinberg, and D. H Zappe Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 217 - 233. [PDF]
|
|
|
|
 |
|
 M. Komajda and M.-C. Wimart Angiotensin converting enzyme inhibition: from viper to patient Heart, September 1, 2000; 84(90001): 11i - 14. [Full Text]
|
|
|
|
 |
|
 R. Maruyama, E. Hatta, K. Yasuda, N. C. E. Smith, and R. Levi Angiotensin-Converting Enzyme-Independent Angiotensin Formation in a Human Model of Myocardial Ischemia: Modulation of Norepinephrine Release by Angiotensin Type 1 and Angiotensin Type 2 Receptors J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 248 - 254. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. MYOU, M. FUJIMURA, K. KURASHIMA, H. TACHIBANA, K. WATANABE, and T. HIROSE Type 1 Angiotensin II Receptor Antagonism Reduces Antigen-induced Airway Reactions Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 45 - 49. [Abstract] [Full Text]
|
|
|
|
|
|
H. Urata Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2_suppl): S35 - S37. [Abstract] [PDF]
|
|
|
|
|
|
N. K. Hollenberg Hypertension, Small Arteries, and Pathways for Angiotensin II Generation : "The Proper Study of Mankind is Man" Circulation, April 11, 2000; 101(14): 1641 - 1642. [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Nakahara, S. Matsushita, H. Matsuoka, T. Inamatsu, M. Nishinaga, M. Yonawa, T. Aono, T. Arai, Y. Ezaki, and H. Orimo Insertion/Deletion Polymorphism in the Angiotensin-Converting Enzyme Gene Affects Heart Weight Circulation, January 18, 2000; 101(2): 148 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Uehara, H. Urata, M. Sasaguri, M. Ideishi, N. Sakata, T. Tashiro, M. Kimura, and K. Arakawa Increased Chymase Activity in Internal Thoracic Artery of Patients With Hypercholesterolemia Hypertension, January 1, 2000; 35(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Hollenberg Implications of Species Difference for Clinical Investigation : Studies on the Renin-Angiotensin System Hypertension, January 1, 2000; 35(1): 150 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wang, A. Zagariya, E. Ang, O. Ibarra-Sunga, and B. D. Uhal Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1245 - L1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. MaassenVanDenBrink, R. de Vries, P. R. Saxena, M. A.D.H. Schalekamp, and A.H.J. Danser Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase Cardiovasc Res, November 1, 1999; 44(2): 407 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Inoue, H. Nishimura, J. Kubota, and K. Kawamura Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I Hypertension, September 1, 1999; 34(3): 525 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Campbell, A.-M. Duncan, and A. Kladis Angiotensin-Converting Enzyme Inhibition Modifies Angiotensin but Not Kinin Peptide Levels in Human Atrial Tissue Hypertension, August 1, 1999; 34(2): 171 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ihara, H. Urata, A. Kinoshita, J. Suzumiya, M. Sasaguri, M. Kikuchi, M. Ideishi, and K. Arakawa Increased Chymase-Dependent Angiotensin II Formation in Human Atherosclerotic Aorta Hypertension, June 1, 1999; 33(6): 1399 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Wilson, L. Saward, P. Zahradka, and P. Kee Cheung Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model Cardiovasc Res, June 1, 1999; 42(3): 761 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wang, A. Zagariya, O. Ibarra-Sunga, C. Gidea, E. Ang, S. Deshmukh, G. Chaudhary, J. Baraboutis, G. Filippatos, and B. D. Uhal Angiotensin II induces apoptosis in human and rat alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L885 - L889. [Abstract] [Full Text] [PDF]
|
|